AB
MNTA

Amalgamated Bank’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Amalgamated Bank’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-18,780
Closed -$986K – 1618
2020
Q3 		$986K Sell
18,780
-592
-3% -$24.5K 0.04% 455
2020
Q2 		$645K Sell
19,372
-692
-3% -$22K 0.03% 673
2020
Q1 		$546K Buy
20,064
+1,108
+6% +$30.8K 0.01% 862
2019
Q4 		$374K Buy
18,956
+625
+3% +$9.99K 0.01% 1276
2019
Q3 		$238K Sell
18,331
-169
-0.9% -$2.04K 0.01% 1457
2019
Q2 		$230K Buy
18,500
+3,782
+26% +$50.2K 0.01% 1507
2019
Q1 		$214K Buy
14,718
+2,390
+19% +$30.5K 0.01% 1478
2018
Q4 		$136K Buy
+12,328
New +$172K ﹤0.01% 1481
2018
Q3 		– Sell
-12,544
Closed -$257K – 1696
2018
Q2 		$257K Buy
12,544
+1,739
+16% +$37.3K 0.01% 1420
2018
Q1 		$196K Sell
10,805
-120
-1% -$2K 0.01% 1467
2017
Q4 		$152K Buy
+10,925
New +$148K ﹤0.01% 1545

Amalgamated Bank's MNTA Position: Q4 2020 in Review

Amalgamated Bank sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 18,780 shares — an estimated $986K sold.

Amalgamated Bank first reported a position in MNTA in Q4 2017 and held it in 11 quarters. The position peaked at $986K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Amalgamated Bank reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Amalgamated Bank sold 18,780 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $986K.
  • Amalgamated Bank first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2017 and held it in 11 quarters.
  • Amalgamated Bank's Momenta Pharmaceuticals, Inc. position peaked at $986K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Amalgamated Bank's 13F filing for Q4 2020, filed 12 Feb 2021.